1. Volume 73, Issue 3, Pages 436-444 (March 2018)
Impact of Early Salvage Radiation Therapy in Patients with Persistently Elevated or Rising Prostate-specific Antigen After Radical Prostatectomy 
Nicola Fossati, R. Jeffrey Karnes, Michele Colicchia, Stephen A. Boorjian, Alberto Bossi, Thomas Seisen, Nadia Di Muzio, Cesare Cozzarini, Barbara Noris Chiorda, Claudio Fiorino, Giorgio Gandaglia, Paolo Dell’Oglio, Shahrokh F. Shariat, Gregor Goldner, Steven Joniau, Antonino Battaglia, Karin Haustermans, Gert De Meerleer, Valérie Fonteyne, Piet Ost, Hendrik Van Poppel, Thomas Wiegel, Francesco Montorsi, Alberto Briganti 
European Urology 
Volume 73, Issue 3, Pages (March 2018)
DOI: /j.eururo
Copyright © 2017 European Association of Urology Terms and Conditions

2. Fig. 1
A risk stratification tree assessing metastasis-free survival (MFS), based on 925 patients treated with salvage radiation therapy for prostate-specific antigen (PSA) rise after radical prostatectomy.
European Urology  , DOI: ( /j.eururo )
Copyright © 2017 European Association of Urology Terms and Conditions

3. Fig. 2
Probability of metastasis-free survival at 8 yr after radical prostatectomy (RP) plotted against the prostate-specific antigen (PSA) level at salvage treatment. Patients were stratified according to risk groups.
SRT=salvage radiation therapy.
European Urology  , DOI: ( /j.eururo )
Copyright © 2017 European Association of Urology Terms and Conditions